BAL Bioenergy AF.(See LSE:SBLM)

    

Miscellaneous urgent priority

 
Disclosure pursuant to Art. 21 of the Stock Exchange Act
 
 
Basel, 4 August 2008. Notification by B�loise-Holding, Aeschengraben 21,
CH­4002 Basel, Switzerland
 
B�loise-Holding hereby discloses that Barclays Plc, 1 Churchill Place, London,
E14 5HP, with its subsidiaries as set out below, exceeded the 10% shareholding
threshold on 30 July 2008 owing to the B�loise-Holding capital reduction
entered in the Commercial Register on 24 July 2008 and published in the Swiss
Commercial Gazette (Schweizerisches Handelsamtsblatt) on 30 July 2008, and that
said company, together with 
 
�         Barclays Global Investors Japan Trust & Banking Co Ltd, Ebisu Prime
Square Tower, 1-1-39 Hiroo, Shibuya-ku, Tokyo 150-8402, Japan
�         Barclays Global Investors Japan Ltd, Ebisu Prime Square Tower,
1-1-39 Hiroo, Shibuya-ku, Tokyo 150-8402, Japan
�         Barclays Global Investors Ltd, 1 Churchill Place, London E14 5HP, UK
�         Barclays Bank Plc, 1 Churchill Place, London E14 5HP, UK
�         Barclays Life Assurance Co Ltd, 1 Churchill Place, London E14 5HP,
UK
�         Barclays Global Investors (Deutschland) AG, Max-Joseph Strasse 6,
80333 M�nchen, Germany
�         Barclays Global Investors NA, 400 Howard Street, San Francisco,
California 94105-2618, USA
�         Barclays Global Fund Advisors, 400 Howard Street, San Francisco,
California 94105-2618, USA
�         Barclays Global Investors Canada Ltd, BCE Place, 161 Bay Street,
Suite 2500, Box 614, Toronto, Ontario M5J 2S1, Canada
�         Barclays Global Investors Australia Ltd, Level 43, Grosvenor Place,
225 George Street, Sydney, NSW 2000, Australia
 
holds 5,360,483 registered shares of B�loise-Holding, corresponding to 10.72%
of the 50,000,000 outstanding shares of B�loise-Holding.
 

------------------------------------------------

 


Head Office of the Baloise Group: Aeschengraben 21, CH-4002 Basel
 
Internet: www.baloise.com (http://www.baloise.com/)   
 
E-mail: media.relations@baloise.com / investor.relations@baloise.com
 
Investor Relations: Tel.      +41 61 285 81 81           Fax +41 61 285 75 62
Media Relations:    Tel.      +41 61 285 84 67           Fax +41 61 285 90 06
 

------------------------------------------------

 
Headquartered in Basel, Switzerland and with operations in Continental Europe,
the Baloise Group is a solution provider in the fields of security and provision
for the future. The Baloise's strategy focuses on sustained, high-yield growth
in the preferred target segments. Its core markets are Switzerland, Germany,
Belgium, Luxembourg, Austria, Croatia and Serbia. The Baloise Group employs some
8,600 people. B�loise-Holding registered shares are included in the Swiss
Market Index (SMI) and are traded under the symbol BALN.

Publication:
http://inbox.newsbox.ch/publish/baloise/18_63/Offenlegung_Barclays_04_08_08_E.pdf


--- END - Last touched by the Tensid Systems @ 2008-08-04 15:00:20 UTC
-------------------------------------------------------------------------------
Provider: Tensid Ltd., Switzerland, http://www.tensid.ch
Channel:  newsbox.ch
Contact:  marco@tensid.ch or phone +41 41 763 00 50
-------------------------------------------------------------------------------

Grafico Azioni Bioenergy AF.(See LSE:SBLM) (LSE:BAL)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni Bioenergy AF.(See LSE:SBLM) (LSE:BAL)
Storico
Da Giu 2023 a Giu 2024